Literature DB >> 19007504

Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence.

Robert S Goodwin1, William D Darwin, C Nora Chiang, Ming Shih, Shou-Hua Li, Marilyn A Huestis.   

Abstract

The time course of 11-nor-9-carboxy-Delta9-tetrahydrocannnabinol (THCCOOH) elimination in urine was characterized in 60 cannabis users during 24 h monitored abstinence on a closed research unit for up to 30 days. Six thousand, one hundred fifty-eight individual urine specimens were screened by immunoassay with values > or = 50 ng/mL classified as positive. Urine specimens were confirmed for THCCOOH by gas chromatography-mass spectrometry following base hydrolysis and liquid-liquid or solid-phase extraction. In 60%, the maximum creatinine normalized concentration occurred in the first urine specimen; in 40%, peaks occurred as long as 2.9 days after admission. Data were divided into three groups, 0-50, 51-150, and > 150 ng/mg, based on the creatinine corrected initial THCCOOH concentration. There were statistically significant correlations between groups and number of days until first negative and last positive urine specimens; mean number of days were 0.6 and 4.3, 3.2 and 9.7, and 4.7 and 15.4 days, respectively, for the three groups. These data provide guidelines for interpreting urine cannabinoid test results and suggest appropriate detection windows for differentiating new cannabis use from residual drug excretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007504      PMCID: PMC2587336          DOI: 10.1093/jat/32.8.562

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  15 in total

1.  Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology.

Authors:  William A Vega; Sergio Aguilar-Gaxiola; Laura Andrade; Rob Bijl; Guilherme Borges; Jorge J Caraveo-Anduaga; David J DeWit; Steven G Heeringa; Ronald C Kessler; Bo Kolody; Kathleen R Merikangas; Beth E Molnar; Ellen E Walters; Lynn A Warner; Hans-Ulrich Wittchen
Journal:  Drug Alcohol Depend       Date:  2002-12-01       Impact factor: 4.492

2.  Differentiating new marijuana use from residual drug excretion in occasional marijuana users.

Authors:  M A Huestis; E J Cone
Journal:  J Anal Toxicol       Date:  1998-10       Impact factor: 3.367

3.  Solid-phase extraction of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid from urine drug-testing specimens with the cerex polycrom-THC column.

Authors:  D K Crockett; G Nelson; P Dimson; F M Urry
Journal:  J Anal Toxicol       Date:  2000 May-Jun       Impact factor: 3.367

4.  Solid-phase extraction and GC-MS analysis of THC-COOH method optimized for a high-throughput forensic drug-testing laboratory.

Authors:  P R Stout; C K Horn; K L Klette
Journal:  J Anal Toxicol       Date:  2001-10       Impact factor: 3.367

5.  Persistence of urinary marijuana levels after supervised abstinence.

Authors:  C A Dackis; A L Pottash; W Annitto; M S Gold
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

6.  The confirmation of 9-carboxy-THC in urine by gas chromatography/mass spectrometry.

Authors:  J D Whiting; W W Manders
Journal:  Aviat Space Environ Med       Date:  1983-11

7.  Tolerance and disposition of tetrahydrocannabinol in man.

Authors:  C A Hunt; R T Jones
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

8.  Apparent half-life of excretion of cannabinoids in man.

Authors:  J S Cridland; D Rottanburg; A H Robins
Journal:  Hum Toxicol       Date:  1983-10

Review 9.  Creatinine: a review.

Authors:  S Narayanan; H D Appleton
Journal:  Clin Chem       Date:  1980-07       Impact factor: 8.327

10.  Marijuana use: persistence and urinary elimination.

Authors:  R Swatek
Journal:  J Subst Abuse Treat       Date:  1984
View more
  31 in total

1.  Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-07-06       Impact factor: 3.786

2.  Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.

Authors:  John Lewis; Anna Molnar; David Allsop; Jan Copeland; Shanlin Fu
Journal:  Int J Legal Med       Date:  2015-08-02       Impact factor: 2.686

3.  Erratum To: Implementation of a Blind Quality Control Program in Blood Alcohol Analysis.

Authors:  Jackeline Moral; Callan Hundl; Dayong Lee; Maddisen Neuman; Aimee Grimaldi; Maria Cuellar; Peter Stout
Journal:  J Anal Toxicol       Date:  2021-05-14       Impact factor: 3.367

4.  Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.

Authors:  Marilyn A Huestis; Cristina Sempio; Matthew N Newmeyer; Maria Andersson; Allan J Barnes; Osama A Abulseoud; Benjamin C Blount; Jennifer Schroeder; Michael L Smith
Journal:  J Anal Toxicol       Date:  2020-10-12       Impact factor: 3.367

5.  Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.

Authors:  Rachel A Rabin; Mera S Barr; Michelle S Goodman; Yarissa Herman; Konstantine K Zakzanis; Stephen J Kish; Michael Kiang; Gary Remington; Tony P George
Journal:  Neuropsychopharmacology       Date:  2017-04-26       Impact factor: 7.853

Review 6.  Cannabis in sport: anti-doping perspective.

Authors:  Marilyn A Huestis; Irene Mazzoni; Olivier Rabin
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

7.  Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.

Authors:  Randi Melissa Schuster; Kevin Potter; Ryan Vandrey; Maya Hareli; Jodi Gilman; David Schoenfeld; A Eden Evins
Journal:  J Psychopharmacol       Date:  2019-09-19       Impact factor: 4.153

8.  ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites.

Authors:  Nicholas Connors; Michael J Kosnett; Ken Kulig; Lewis S Nelson; Andrew I Stolbach
Journal:  J Med Toxicol       Date:  2020-01-14

9.  A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users.

Authors:  Randi Melissa Schuster; Ailish Hanly; Jodi Gilman; Alan Budney; Ryan Vandrey; A Eden Evins
Journal:  Drug Alcohol Depend       Date:  2016-08-28       Impact factor: 4.492

10.  In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.

Authors:  Nathalie A Desrosiers; Dayong Lee; Karl B Scheidweiler; Marta Concheiro-Guisan; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-12-01       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.